Resultados de búsqueda - Michal Mark‐Danieli

  • Mostrando 1 - 2 Resultados de 2
Limitar resultados
  1. 1
    Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target

    Resistance or sensitivity of Wilms’ tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target por Naomi Pode‐Shakked, Orit Harari‐Steinberg, Y. Haberman-Ziv, Eithan Rom‐Gross, S Bahar, Dashne Shamall Omer, Sally Metsuyanim, Ella Buzhor, Jasmin Jacob–Hirsch, Ronald S. Goldstein, Michal Mark‐Danieli, Benjamin Dekel

    Publicado 2011
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  2. 2
    The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

    The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets por Naomi Pode‐Shakked, Rachel Shukrun, Michal Mark‐Danieli, Peter Tsvetkov, Sarit Bahar, Sara Pri‐Chen, Ronald S. Goldstein, Eithan Rom‐Gross, Yoram Mor, Eddie Fridman, Karen Meir, Amos J. Simon, Marcus J. Magister, Naftali Kaminski, Victor S. Goldmacher, Orit Harari‐Steinberg, Benjamin Dekel

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: